Financial

Turacoz Group Leads the Future of Evidence Synthesis With AI-Powered Living Systematic Reviews at World Evidence, Pricing and Access (EPA) Congress, Europe 2025

UTRECHT, Netherlands, March 12, 2025 /PRNewswire/ -- Turacoz Group, a leader in real-world evidence (RWE) and health economics and outcomes...

Grace: Triple HITRUST Certification Covers Full Stack Cloud Platform | Over 500,000 Annual Calls | 500K Pints of Life-Saving Blood Collected

LOS ANGELES, March 12, 2025 /PRNewswire/ -- Gridspace proudly announces that its pioneering virtual voice health agent, Grace, has earned...

BioXcel Therapeutics Strengthens Cash Position to Advance SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia

Molecular Spectroscopy Market Size Booms with CAGR 4.9% and Projected to Reach $5.6 Million by 2030 | Exclusive Report by The Insight Partners

NEW YORK, March 6, 2025 /PRNewswire/ -- According to a comprehensive report from The Insight Partners, "Molecular Spectroscopy Market share and...

Hemostemix and FireFly Neuroscience’s Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01

A growing body of clinical evidence supports the use of Firefly's FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment...

error: Content is protected !!